Akero Therapeutics (AKRO) PT Raised to $96 at Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Michael Ulz raised the price target on Akero Therapeutics (NASDAQ: AKRO) to $96.00 (from $46.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
